(R)-3-羟基丁酸, ≥98%

(R)-3-Hydroxybutanoic acid

(S)-2-(2-羟乙基)哌啶盐酸盐, 98%

(S)-2-(2-Hydroxyethyl)piperidine hydrochloride

(R)双[(4S)-(苯基)恶唑-2-基)]-7,7,-2,2,3,3-四氢-1,1,6,6'-二醇, 99%

Oxazole,2,2'-[(1R)-2,2',3,3'-tetrahydro-1,1'-spirobi[1H-indene]-7,7'-diyl]bis[4,5-dihydro-4-phenyl-,(4S,4'S)-

D-(+)-新蝶呤, ≥98.0%(sum of enantiomers,HPLC)

D-Neopterin

(S)-吲哚啉-2-基甲醇, 98%

(S)-吲哚啉-2-基甲醇

2-(哌嗪-1-基)苯酚盐酸盐, 98%

2-(Piperazin-1-yl)phenol hydrochloride

（4R，5S）-3，3a，8，8a-四氢茚并[1,2-d]-1,2,3-氧杂噻唑-2,2-二氧化物-3-羧酸叔丁酯

(4R,5S)-3,3a,8,8a-Tetrahydroindeno[1,2-d]-1,2,3-oxathiazole-2,2-dioxide-3-carboxylic acid t-butyl ester

≥98%

巯基胆固醇,

THIOCHOLESTEROL

(4R,4'R,5S,5'S)-2,2'-(1-Methylethylidene)bis[4,5-dihydro-4,5-diphenyloxazole], ≥99%,99.9%e.e.

(4R,4'R,5S,5'S)-2,2'-(1-Methylethylidene)bis[4,5-dihydro-4,5-diphenyloxazole]

(1S,2S)-N,N'-二甲基-1,2-二苯基-1,2-乙二胺, 99%

(1S,2S)-(-)-N,N'-DIMETHYL-1,2-DIPHENYL-1,2-ETHANE DIAMINE

N-苄基奎宁氯[手性相转移催化剂], 95.0%

N-Benzylquininium Chloride [Chiral Phase-Transfer Catalyst]

（2R）-（+）-1,1-双（4-甲氧基苯基）-3-甲基-1,2-丁二胺

(2R)-(-)-1,1-Bis(4-methoxyphenyl)-3-methyl-1,2-butanediamine

98%

(4R,4'R,5S,5'S)-2,2'-环丙亚基双[4,5-二氢-4,5-二苯基噁唑], 99%

(4R,4'R,5S,5'S)-2,2'-cyclopropylidenebis[4,5-dihydro-4,5-diphenyl-Oxazole

3-氯-4-羟基-5-硝基苯甲酸甲酯, 99%

Methyl 3-chloro-4-hydroxy-5-nitrobenzoate

2,6-双((4R,5S)-4,5-二苯基-4,5-二氢恶唑-2-基)吡啶, 98%,99.9%ee

2,6-Bis((4R,5S)-4,5-diphenyl-4,5-dihydrooxazol-2-yl)pyridine

（R）-（-）-5,5''，6,6''，7,7''，8,8''-八氢-3,3''-二叔丁基-1,1' '-二-2-萘酚，双钾盐

(R)-(-)-5,5'',6,6'',7,7'',8,8''-Octahydro-3,3''-di-t-butyl-1,1''-bi-2-naphthol, dipotassium salt

98%

(S,S)-(+)-2,3-二甲氧基-1,4-双(二甲氨基)丁烷, ≥98%

(S,S)-(+)-2,3-Dimethoxy-1,4-bis(dimethylamino)butane

（4R，5S）-4，5-二苯基-1，2，3-恶噻唑烷-2，2-二氧化物-3-羧酸叔丁酯

(4R,5S)-4,5-Diphenyl-1,2,3-oxathiazolidine-2,2-dioxide-3-carboxylic acid t-butyl ester

≥98%

（R，S）-六氢-3H-1,2,3-苯并噻唑-2,2-二氧化物-3-羧酸叔丁酯

(R,S)-Hexahydro-3H-1,2,3-benzoxathiazole-2,2-dioxide-3-carboxylic acid t-butyl ester

≥98%

3-氮杂二环[3.1.0]己烷-2-羧酸, ≥98%

3-Azabicyclo[3.1.0]hexane-2-carboxylic acid